Compounders Research Compare

Rezolute, Inc.(RZLT)

Biotechnology · Redwood City, CA

$4.25-0.08 (-1.96%)

Delayed quote: Oct 6, 2026, 2:00 PM EDT

About Rezolute, Inc.

Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.

Redwood City, CA

58 employees

www.rezolutebio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Nevan Charles Elam

View full financials

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T18:05:20.887Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:05:20.887Z.

Quote observation: 2026-10-06T18:00:22.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -0.76
Quote price: 4.245

FMP input reference: eb6c183c54b52a3f5be7b88cd35f52a8db6123751fb387d2cb2c86d403628cdc

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

RZLT Earnings Yield Metrics

EARNINGS YIELD

N/A

RZLT Competitors' Earnings Yield

Rezolute, Inc.

Current

Market Cap

$408.76M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Eikon Therapeutics, Inc. Common Stock

Market Cap

$408.45M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Shoulder Innovations, Inc.

Market Cap

$409.37M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Carlsmed, Inc.

Market Cap

$407.13M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Neurogene Inc.

Market Cap

$406.75M

Earnings Yield

N/A

TTM Avg

5.34%

3Y Avg

5.37%

5Y Avg

5.37%

Myriad Genetics, Inc.

Market Cap

$412.62M

Earnings Yield

N/A

TTM Avg

1.28%

3Y Avg

2.85%

5Y Avg

3.31%

Strata Critical Medical, Inc.

Market Cap

$412.30M

Earnings Yield

10.44%

TTM Avg

10.26%

3Y Avg

10.26%

5Y Avg

10.26%

Atea Pharmaceuticals, Inc.

Market Cap

$404.94M

Earnings Yield

N/A

TTM Avg

8.82%

3Y Avg

5.78%

5Y Avg

5.78%

Senseonics Holdings, Inc.

Market Cap

$413.34M

Earnings Yield

N/A

TTM Avg

14.15%

3Y Avg

14.15%

5Y Avg

14.15%

MapLight Therapeutics, Inc.

Market Cap

$397.20M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Rezolute, Inc. (RZLT)	$408.76M	N/A	N/A	N/A	N/A
Eikon Therapeutics, Inc. Common Stock (EIKN)vs ›	$408.45M	N/A	N/A	N/A	N/A
Shoulder Innovations, Inc. (SI)vs ›	$409.37M	N/A	N/A	N/A	N/A
Carlsmed, Inc. (CARL)vs ›	$407.13M	N/A	N/A	N/A	N/A
Neurogene Inc. (NGNE)vs ›	$406.75M	N/A	5.34%	5.37%	5.37%
Myriad Genetics, Inc. (MYGN)vs ›	$412.62M	N/A	1.28%	2.85%	3.31%
Strata Critical Medical, Inc. (SRTA)vs ›	$412.30M	10.44%	10.26%	10.26%	10.26%
Atea Pharmaceuticals, Inc. (AVIR)vs ›	$404.94M	N/A	8.82%	5.78%	5.78%
Senseonics Holdings, Inc. (SENS)vs ›	$413.34M	N/A	14.15%	14.15%	14.15%
MapLight Therapeutics, Inc. (MPLT)vs ›	$397.20M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics